Status and implications of the knowledge, attitudes and practices towards AWaRe antibiotic use, resistance and stewardship among low- and middle-income countries.
Saleem Z. et al, (2025), JAC Antimicrob Resist, 7
Current access, availability and use of antibiotics in primary care among key low- and middle-income countries and the policy implications.
Saleem Z. et al, (2025), Expert review of anti-infective therapy
A pilot protocol for surveillance of infection and antibiotic prescribing in primary healthcare across the globe: Antibiotic Prescribing in Primary Healthcare Point Prevalence Survey (APC-PPS)
Cook A. et al, (2025), Wellcome Open Research, 10, 26 - 26
Global, regional, and national burden of upper respiratory infections and otitis media, 1990–2021: a systematic analysis from the Global Burden of Disease Study 2021
Sirota SB. et al, (2025), The Lancet Infectious Diseases, 25, 36 - 51
Global, regional, and national burden of pulmonary arterial hypertension, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
Leary PJ. et al, (2025), The Lancet Respiratory Medicine, 13, 69 - 79
Knocking Out Antimicrobial Resistance editorial: reflections on the United Nations General Assembly high-level meeting on antimicrobial resistance
Moore CE. and Joshi LT., (2024), Journal of Medical Microbiology, 73
Identifying AWaRe indicators for appropriate antibiotic use: a narrative review
Funiciello E. et al, (2024), Journal of Antimicrobial Chemotherapy
Knocking Out AMR project review
Joshi LT. and Moore CE., (2024), Journal of Medical Microbiology, 73
Advancing global antibiotic research, development and access
Piddock LJV. et al, (2024), Nature Medicine
Global burden associated with 85 pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019
Naghavi M. et al, (2024), The Lancet Infectious Diseases, 24, 868 - 895
Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of Disease Study 2021
Ledesma JR. et al, (2024), The Lancet Infectious Diseases, 24, 698 - 725
Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
Brauer M. et al, (2024), The Lancet, 403, 2162 - 2203
Mapping TB incidence across districts in Uganda to inform health program activities
Henry NJ. et al, (2024), IJTLD OPEN, 1, 223 - 229
System-wide approaches to antimicrobial therapy and antimicrobial resistance in the UK: the AMR-X framework
Abel K. et al, (2024), The Lancet Microbe, 5, e500 - e507
Implementation of an antibiotic resistance surveillance tool in Madagascar, the TSARA project: a prospective, observational, multicentre, hospital-based study protocol
Elias C. et al, (2024), BMJ Open, 14, e078504 - e078504
The burden of bacterial antimicrobial resistance in the WHO African region in 2019: a cross-country systematic analysis
Sartorius B. et al, (2024), The Lancet Global Health, 12, e201 - e216
Diagnostic and antibiotic use practices among COVID-19 and non-COVID-19 patients in the Indonesian National Referral Hospital.
Sinto R. et al, (2024), PloS one, 19
CAPTURA Regional Workshop Proceedings (28–30 June 2022, Virtual)
Joh HS. et al, (2023), Clinical Infectious Diseases, 77, S536 - S542
The Reality of Antimicrobial Resistance and Antibiotic Usage Data in Asia: The CAPTURA Experience
Leslie T. et al, (2023), Clinical Infectious Diseases, 77, S497 - S499